ARCH Venture Partners Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 17
Professionals
  • Investments
  • 540
  • Portfolio
  • 96
  • Exits
  • 225
Exits

ARCH Venture Partners General Information

Description

Founded in 1986, ARCH Venture Partners is a venture capital firm based in Chicago, Illinois. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. The firm seeks to invest in the healthcare, information technology, and commercial services sectors.

Contact Information

Website
www.archventure.com
Year Founded
1986
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Primary Office
  • 8755 West Higgins Road
  • Suite 1025
  • Chicago, IL 60631
  • United States
+1 (773) 000-0000

ARCH Venture Partners Investments (540)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
hC Bioscience 23-Feb-2022 Early Stage VC 0000 Drug Discovery Startup 000000 000000 00.0
00000000 03-Feb-2022 00000 00000 00000 Drug Discovery Generating Revenue
000 20-Jan-2022 00000 00000 0000 Discovery Tools (Healthcare) Generating Revenue/Not Profitable 00000 00000000
000.000 31-Dec-2021 00000 00000 00000 Drug Discovery Generating Revenue
000000 000000 02-Dec-2021 00000 00000 0000 Clinics/Outpatient Services Startup 000000 000000
00000000 000000000 18-Nov-2021 00000 00000 00000 Discovery Tools (Healthcare) Generating Revenue
00000 000000000000 09-Nov-2021 00000 00000 00000 Drug Discovery Pre-Clinical Trials
000000000 00000000 09-Nov-2021 00000 00000 00000 Diagnostic Equipment Generating Revenue
Mozart Therapeutics 26-Oct-2021 Early Stage VC 0000 Drug Discovery Generating Revenue 000000 000000 00.0
Neumora 07-Oct-2021 Early Stage VC 00000 Drug Discovery Clinical Trials - Phase 2 00000000 00000
You’re viewing 10 of 540 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ARCH Venture Partners Exits (225)

Company Name Exit Date Exit Type Exit Size
EQRx 17-Dec-2021 Reverse Merger 00.00
000 0000000 12-Nov-2021 000000 0000000000 00000
0000000000 0000000 07-Oct-2021 000000000000000000
0000000000 0000000 29-Sep-2021 000 000.00
0000000 20-Sep-2021 000000000000000000 00000
00000 18-Aug-2021 000000000000000000 00.00
000000 00000000 11-Aug-2021 000000000000000000 000.00
000000 10-Aug-2021 000000000000000000
Vividion Therapeutics 01-Aug-2021 Merger/Acquisition 00.00
DA32 Life Science Tech Acquisition 28-Jul-2021 IPO 00000
You’re viewing 10 of 225 exits. Get the full list »

ARCH Venture Partners Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore ARCH Venture Partners‘s full profile, request access.

Request a free trial

ARCH Venture Partners Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

ARCH Venture Partners Team (61)

Name Title Deals Funds Boards Office
Mark McDonnell Managing Director, Chief Financial Officer & Chief Administrative Officer 0 0 Chicago, IL
Robert Nelsen Co-Founder and Managing Director 00 0 00 Seattle, WA
Keith Crandell Co-Founder & Managing Director 00 0 0 Chicago, IL
Clinton Bybee Co-Founder & Managing Director, Emeritus 00 0 0 Chicago, IL
Kristina Burow Managing Director 00 0 00 San Francisco, CA
You’re viewing 5 of 61 team members. Get the full list »

ARCH Venture Partners Co-Investors (415)

Name With Exits Lead Partner Series Industry
Alexandria Venture Investments 23 0 0 Series chart Industry bar
GV 00 0 00 Series chart Industry bar
Altitude Life Science Ventures 00 0 0 Series chart Industry bar
Polaris Partners 00 0 0 Series chart Industry bar
Casdin Capital 00 0 0 Series chart Industry bar
You’re viewing 5 of 415 co-investors. Get the full list »